We evaluated the use of transferrin receptor (TfR) in serum as an index of iron deficiency in 19 patients diagnosed as having iron-deficiency anemia, in 17 patients with anemia of chronic disease, and in a control group of 19 nonanemic patients who underwent elective ocular or nasopharyngeal surgery. The assessment of iron status of the anemic patients was based on the presence of stainable iron on bone marrow examination. In the patients with iron-deficiency anemia, the serum TfR concentration was 5.3 ± 1.8 mg/L (mean ± SD), significantly higher than in the control group (1.7 ± 0.5 mg/L) or in the patients with anemia of chronic disease (1.6 ± 0.4 mg/L). This study suggests that serum TfR measurement is a reliable index of iron depletion and potentially of importance in the diagnosis of iron-deficiency anemia. reflects the iron requirement (7). Deprivation of iron results in prompt induction of TIR synthesis (7). Soluble TfR has been identified in human serum and plasma; it is a truncated form of tissue receptor, with the truncation occurring at a site just beyond the cell membrane (8). Recently, serum concentrations of T have been suggested as a reliable index of iron depletion (2, 6, 9-13). In earlier studies of iron depletion, the iron status was not confirmed by bone marrow examination. Therefore, we analyzed serum TfR in a group of anemic patients, and correlated the T concentrations with the type of anemia and presence of stainableiron in bone marrow.
IndexIngTerms:bone marrow staining/ferritin
Iron-deficiency anemia can be caused by dietary deprivation of iron or by iron malabsorbtion and may be the first clinical sign of increased blood loss. Quite often, iron-deficiency anemia warrants extensive investigations of the gastrointestinal tract, given the relatively high probability that ulcers or malignant tumors are the cause of excessive blood loss. The distinction between iron-deficiency anemia and the anemia that accompanies infection, inflammation, or malignancy is not clear; the commonly used laboratory tests do not necessarily distinguish these common causes of anemia (1,2 
Results and Discussion
We analyzed serum Tifi concentrations and performed conventional laboratory tests in anemic patients and correlated the results with the type of anemia and presence of iron in bone marrow. A total of 36 anemic patients participated in this study, and the results for blood counts and iron status markers are presented in Table 1 . Common practice in Finland includes measuring the complete blood count, serum iron, transferrin, and ferritin when examining anemic patients. In patients with no chronic disease these values have been helpful in clinical decision-making. However, acutephase responses make the interpretation of the laboratory data difficult, given that both serum ferritin and serum transferrin are acute-phase reactants, the former increasing and the latter decreasing in acute illness (3,
14, 16-18).
Serum iron concentration is lower in patients with iron-deficiency anemia than in healthy subjects, but it cannot be used to distinguish iron-deficiency anemia from anemia of chronic disease. In the present study the mean serum transferrin concentration was slightly higher in the patients with iron-deficiency anemia than in the controls (Table 1) , but the iron saturation of transferrin calculated as the TI is more useful than either serum iron or serum transferrin alone (15) (Fig. 1, top) . The mean serum ferritin concentration was lower in patients with iron-deficiency anemia (9 ± 6 mean ± SD) than in the controls (72 ± 89 1zg/L, mean ± SD), but was significantly increased in the patients with anemia of chronic disease (288 ± 274 pgIL) ( Table 1) . Thus, the use of ferritin as a marker of iron deficiency is complicated by the acute-phase responses associated with chronic disease.
We evaluated the use of serum TfR as an index of body iron status in anemic patients and correlated the T concentration with the presence of iron stores in bone marrow. The individual values of transferrin, TI, ferritin, and T are shown in Fig. 1 . In the patients who had anemia fulfilling the morphological criteria of irondeficiency anemia and no stainable iron on bone marrow examination, the serum TfR concentration was 5.3 ± 1.8 mgfL, significantly higher than that in the control group (1.7 ± 0.5 mgfL). In 18 of the 19 patients with irondeficiency anemia, the serum TfR concentration was higher than in any of the control subjects. In the patients with anemia of chronic disease (and readily stain-able iron in bone marrow), the serum Tifi concentration was 1.6 ± 0.4 mg/L, essentially equal to that in the control group. The values in the control group were well within the reference range provided by the kit manufacturer. Earlier studies have varied considerably in the concentrations reported for serum and plasma T, apparently because of the different specificities of the antibodies they used (6) .
Clearly, a more specific index of iron-deficient erythropoiesis is needed. Serum concentrations of T have been suggested to reflect the availability of iron for erythropoiesis (1, 10, 11 ). So far no published studies have correlated the serum TIE concentrations with the true iron status (based on bone marrow examination).
In the present study, we found that high serum TIE concentrations could effectively identify the patients with true iron deficiency (confirmed on the basis of absence of stainable iron in bone marrow) and that serum TIE measurements could also distinguish patients with irondeficiency anemia from those with anemia of chronic disease. TIE measurement seems to provide a means of identifying iron depletion even in patients with acutephase reactions associated with inflammatory conditions (1, 2) ; however, the effectiveness of TIE measurements in identifying latent iron deficiency remains to be evaluated.
Earlier studies reported increased TIE concentrations in association with, e.g., increased erythropoiesis, hemolytic anemias, and acute leukemias (2, 13,
19, 20). However, none of these conditions generally
constitutes a clinical problem in the identification of iron-deficiency anemia.
On the basis of the present study, consistent with other previous reports (1,2, 10), we conclude that the serum TIE concentration is a useful serum marker of iron depletion.
